Actively Recruiting
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Led by Case Comprehensive Cancer Center · Updated on 2026-05-08
30
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Undergoing cancer treatment comes with various risks and side effects. This clinical trial aims to reduce those risks and side effects through continuous monitoring of vital signs and blood levels. The goal is to see if potential side effects can be identified and treated sooner. During this study, participants will wear an Alio Smartpatch™. The Alio Smartpatch™ is a wireless remote monitoring system. This device will measure participants' vital signs and blood levels. Participants will also be asked to use continuous glucose monitors to measure their glucose levels. The data collected on each participant from these devices will be remotely monitored at all times by clinical staff at a company known as Quantify Remote Care. If a participant's results look like they are experiencing a side effect, the participant will be contacted immediately by Quantify Remote Care team. The Quantify Remote Care team will function as an extension of the participant's cancer clinical team and will relay any significant issues back to them. Quantify Health also provides dietary and mental health support as needed for all participants.
CONDITIONS
Official Title
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of soft tissue sarcoma, NSCLC, HNSCC, breast, pancreatic cancer, or melanoma
- Starting a new chemotherapy regimen with high (>20%) or intermediate risk of febrile neutropenia with additional risk factors
- Starting immunotherapy alone or combined with chemotherapy
- Able to give informed consent
- Able to read and/or speak English
- Age between 18 and 65 years
- Expected chemotherapy duration of at least 12 weeks
You will not qualify if you...
- Unable to read or speak English
- No access to a cellphone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center
Cleveland, Ohio, United States, 44106
Actively Recruiting
Research Team
A
Alberto Montero, MD, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here